NCT03135392

Brief Summary

Tissue Expander/Implant Reconstruction: The purpose of this study is to determine how and when nerve sensation to the breast skin returns after mastectomy. Autologous Tissue Reconstruction: The purpose of this study is to determine whether the tissue being used to reconstruct your breast can provide sensation by using your own nerves. Typically all sensation is lost immediately after this type of surgery and returns to varying degrees. We are hoping to demonstrate that by connecting the two nerves (one from abdomen and one from the chest wall) together, we can attain meaningful sensation in the transferred tissues thereby improving your quality of life following surgery.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 1, 2017

Completed
1.4 years until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

November 14, 2018

Status Verified

November 1, 2018

Enrollment Period

2 years

First QC Date

April 27, 2017

Last Update Submit

November 12, 2018

Conditions

Keywords

Breast Cancersensation recoveryNeurotization

Outcome Measures

Primary Outcomes (1)

  • Composite measure of sensation

    Differences of at least 20% comparing control to experimental breasts would be clinically meaningful. Composite measure will be calculated by combining the follow binomial factors: detection of temperature difference (feeling hot and cold), detection of sharp versus dull pressure, detection of vibration, discerning point pressure

    Up to 24 months after surgery

Secondary Outcomes (1)

  • Quality of Life as measured by a 19-question survey regarding sensation and appearance of breast.

    Up to 24 months after surgery

Study Arms (3)

Breast Reconstruction with Artificial Implant

ACTIVE COMPARATOR

Participants undergoing unilateral reconstruction: patient will serve as internal control with contralateral breast and reconstructed breast will be compared to all other reconstructed breasts. Participants undergoing bilateral reconstruction: reconstructed breasts will be compared to all other reconstructed breasts

Procedure: Breast Reconstruction with Artificial Implant

Autologous Breast Reconstruction without Neurotization

ACTIVE COMPARATOR

Participants undergoing autologous tissue (her own tissue from other areas of the body) reconstruction which do not have their nerves reconstructed during surgery

Procedure: Autologous Breast Reconstruction

Autologous Breast Reconstruction with Neurotization

EXPERIMENTAL

Participants undergoing autologous tissue (her own tissue from other areas of the body) reconstruction which have a nerve connected (neurotized) during surgery.

Procedure: Autologous Breast ReconstructionProcedure: Neurotization

Interventions

Patients undergo unilateral or bilateral reconstruction of breasts after nipple sparing mastectomy. Breasts are reconstructed with artificial implants

Breast Reconstruction with Artificial Implant

Patients undergo unilateral or bilateral reconstruction of breasts after nipple sparing mastectomy. Breasts are reconstructed with the patient's own tissue

Autologous Breast Reconstruction with NeurotizationAutologous Breast Reconstruction without Neurotization
NeurotizationPROCEDURE

Nerve will be reconstructed during autologous breast tissue reconstruction

Also known as: Nerve Reconstruction
Autologous Breast Reconstruction with Neurotization

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing unilateral or bilateral skin sparing mastectomy for breast cancer
  • Patient must have one of the following reconstructions in planned:
  • Immediate tissue expander placement
  • Immediate implant placement
  • Immediate autologous breast reconstruction
  • All patients participating in the study must be willing to be consented for enrollment at the pre-operative visit.

You may not qualify if:

  • Pre-operative radiation therapy
  • Any pre-excising
  • Patients with absent or prior damaged nipple areola-complex (NAC) on the "non-surgical breast"

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic, Case Comprehensive Cancer Center

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

MammaplastyProstheses and ImplantsNerve Transfer

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Cosmetic TechniquesTherapeuticsPlastic Surgery ProceduresSurgical Procedures, OperativeEquipment and SuppliesNeurosurgical Procedures

Study Officials

  • Andrea Moreira, MD

    Cleveland Clinic, Case Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants who are having implant reconstruction will act as controls for all other breast reconstructions. If the participant is having autologous tissue reconstruction, she will be randomly put into one of the study groups. Neither the study doctor nor the participant can choose the treatment. Assignment is done randomly, like the flip of a coin. If the participant is having only one breast reconstructed, she will be randomly assigned to either receive the nerve reconstruction or not. If the participant is having both of her breasts reconstructed, one side will receive the nerve reconstruction and one will not. The participant will not know which group you have been assigned to until the completion of the study or if voluntarily withdraw from the study
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a prospective cohort study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2017

First Posted

May 1, 2017

Study Start

October 1, 2018

Primary Completion

October 1, 2020

Study Completion

October 1, 2020

Last Updated

November 14, 2018

Record last verified: 2018-11

Locations